NATHANIEL BURGI: Open Payments
NPI 1669024923 · LEHI, UT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$255 in 12 payments from 10 companies in 2025. Trend: 2023 $54 · 2024 $227 · 2025 $255
Food & beverage: $255
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 3 | $72 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $31 |
| Otsuka America Pharmaceutical, Inc. | 1 | $27 |
| Axsome Therapeutics, Inc. | 1 | $25 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $24 |
| Janssen Pharmaceuticals, Inc | 1 | $17 |
| Supernus Pharmaceuticals, Inc. | 1 | $15 |
| Boston Scientific Corporation | 1 | $14 |
| AstraZeneca Pharmaceuticals LP | 1 | $14 |
| PFIZER INC. | 1 | $14 |
Products named: VRAYLAR, REXULTI, Symbravo, CAPLYTA, SPRAVATO, Qelbree, WaveWriter Alpha Prime 16, FARXIGA.
Industry payments across UT — which companies pay providers there.
